Protection of the liver against CCl4-induced injury by intramuscular electrotransfer of a kallistatin-encoding plasmid

World Journal of Gastroenterology

Volumn 17, Issue 1, 2011, Pages 111-117

  Diao, Yong ^a   Zhao, Xiao Feng ^a   Lin, Jun Sheng ^b   Wang, Qi Zhao ^a   Xu, Rui An ^a  

^a HUAQIAO UNIVERSITY   (China)

^b INVERMAY AGRICULTURAL CENTRE   (New Zealand)

Author keywords

Drug formulation; Electroporation; Gene delivery systems; Kallistatin; Liver injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA GALACTOSIDASE; CARBON TETRACHLORIDE; MALONALDEHYDE; PROTEIN KALLISTATIN; SERINE PROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; KALLISTATIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ELECTROPORATION; FIBROGENESIS; GENE EXPRESSION; GENE TRANSFER; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER HEMORRHAGE; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; MOUSE; MUSCLE INJURY; NONHUMAN; OXIDATIVE STRESS; PLASMID; SKELETAL MUSCLE; TRANSGENE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; DRUG EFFECT; FEMALE; GENE THERAPY; GENETICS; INTOXICATION; LIVER; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BIOLOGICAL MARKERS; CARBON TETRACHLORIDE; CARBON TETRACHLORIDE POISONING; ELECTROPORATION; FEMALE; GENE THERAPY; LIVER; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; PLASMIDS; SERPINS; TRANSFORMING GROWTH FACTOR BETA1; TRANSGENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78651502300     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i1.111     Document Type: Article

References (23)

1. Alberts B. The breakthroughs of 2009. Science 2009; 326: 1589
2. Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM, Delaere P, Branellec D, Schwartz B, Scherman D. Highefficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999; 96: 4262-4267
3. Bloquel C, Fabre E, Bureau MF, Scherman D. Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applications. J Gene Med 2004; 6 Suppl 1: S11-S23
4. André FM, Gehl J, Sersa G, Préat V, Hojman P, Eriksen J, Golzio M, Cemazar M, Pavselj N, Rols MP, Miklavcic D, Neumann E, Teissié J, Mir LM. Efficiency of high- and lowvoltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther 2008; 19: 1261-1271
5. Cukjati D, Batiuskaite D, André F, Miklavcic D, Mir LM. Real time electroporation control for accurate and safe in vivo non-viral gene therapy. Bioelectrochemistry 2007; 70: 501-507
6. Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M, Bracko M, Pecnik T, Gadzijev E, Sersa G. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed Eng Online 2010; 9: 10
7. Hui SW. Overview of drug delivery and alternative methods to electroporation. Methods Mol Biol 2008; 423: 91-107
8. Ferber D. Gene therapy. Safer and virus-free? Science 2001; 294: 1638-1642
9. Nicol F, Wong M, MacLaughlin FC, Perrard J, Wilson E, Nordstrom JL, Smith LC. Poly-L-glutamate, an anionic polymer, enhances transgene expression for plasmids delivered by intramuscular injection with in vivo electroporation. Gene Ther 2002; 9: 1351-1358
10. Chao J, Yin H, Yao YY, Shen B, Smith RS Jr, Chao L. Novel role of kallistatin in protection against myocardial ischemiareperfusion injury by preventing apoptosis and inflammation. Hum Gene Ther 2006; 17: 1201-1213
11. Gao L, Yin H, S Smith R Jr, Chao L, Chao J. Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarction. Lab Invest 2008; 88: 1157-1166
12. Shen B, Hagiwara M, Yao YY, Chao L, Chao J. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress. Hypertension 2008; 51: 1358-1365
13. Wang CR, Chen SY, Wu CL, Liu MF, Jin YT, Chao L, Chao J. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation. Arthritis Rheum 2005; 52: 1319-1324
14. Tuñón MJ, Alvarez M, Culebras JM, González-Gallego J. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol 2009; 15: 3086-3098
15. Diao Y, Ma J, Xiao WD, Luo J, Li XY, Chu KW, Fung PW, Habib N, Farzaneh F, Xu RA. Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistatin. World J Gastroenterol 2007; 13: 4615-4619
16. Xu R, Harrison PM, Chen M, Li L, Tsui TY, Fung PC, Cheung PT, Wang G, Li H, Diao Y, Krissansen GW, Xu S, Farzaneh F. Cytoglobin overexpression protects against damage-induced fibrosis. Mol Ther 2006; 13: 1093-1100
17. de Meijer VE, Sverdlov DY, Popov Y, Le HD, Meisel JA, Nosé V, Schuppan D, Puder M. Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice. PLoS One 2010; 5: e11256
18. Fewell JG, MacLaughlin F, Mehta V, Gondo M, Nicol F, Wilson E, Smith LC. Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. Mol Ther 2001; 3: 574-583
19. Gaymalov ZZ, Yang Z, Pisarev VM, Alakhov VY, Kabanov AV. The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells. Biomaterials 2009; 30: 1232-1245
20. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumours. Eur J Surg Oncol 2008; 34: 232-240
21. Testori A, Tosti G, Martinoli C, Spadola G, Cataldo F, Verrecchia F, Baldini F, Mosconi M, Soteldo J, Tedeschi I, Passoni C, Pari C, Di Pietro A, Ferrucci PF. Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach. Dermatol Ther 2010; 23: 651-661
22. Villemejane J, Mir LM. Physical methods of nucleic acid transfer: general concepts and applications. Br J Pharmacol 2009; 157: 207-219
23. Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, Munster PN, Sullivan DM, Ugen KE, Messina JL, Heller R. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26: 5896-5903